marketcaparena
Search

    AVTX

    Avalo Therapeutics, Inc.

    Company overview

    Market capitalization
    $808.74M
    Employees
    33
    Latest publication
    2026-09-29
    About Avalo Therapeutics, Inc.

    Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD59,000USD0USD0USD0USD192,000USD249,000USD0USD
    Cost Of Revenue17,000USD16,000USD9,990,000USD10,660,000USD5,912,000USD87,000USD-714,000USD343,000USD
    Gross Profit-17,000USD59,000USD-9,990,000USD-10,660,000USD-5,912,000USD105,000USD963,000USD-343,000USD
    Research Development14,047,000USD13,267,000USD13,621,000USD14,074,000USD9,123,000USD8,183,000USD9,538,000USD4,704,000USD
    Selling General Administrative6,854,000USD6,153,000USD5,555,000USD5,186,000USD5,534,000USD4,444,000USD4,144,000USD4,507,000USD
    Total Operating Expenses20,884,000USD19,801,000USD9,208,000USD8,656,000USD8,757,000USD13,416,000USD13,824,000USD9,232,000USD
    Operating Income-20,901,000USD-19,742,000USD-19,198,000USD-19,316,000USD-14,669,000USD-13,311,000USD-12,861,000USD-9,575,000USD
    Interest Income803,000USD—1,117,000USD1,102,000USD1,148,000USD—964,000USD1,039,000USD
    Net Interest Income803,000USD984,000USD1,117,000USD1,102,000USD1,148,000USD1,216,000USD964,000USD1,039,000USD
    Income Before Tax-19,618,000USD-13,590,000USD-30,614,000USD-20,749,000USD-13,141,000USD-35,225,000USD23,023,000USD98,470,000USD
    Income Tax Expense12,000USD130,000USD11,000USD16,000USD8,000USD114,000USD-14,000USD7,000USD
    Tax Provision12,000USD130,000USD11,000USD16,000USD8,000USD114,000USD-14,000USD7,000USD
    Net Income-19,630,000USD-13,720,000USD-30,625,000USD-20,765,000USD-13,149,000USD-35,339,000USD23,037,000USD98,463,000USD
    Net Income From Continuing Ops-19,630,000USD-13,720,000USD-30,625,000USD-20,765,000USD-13,149,000USD-35,339,000USD23,037,000USD98,463,000USD
    Ebit-19,618,000USD-13,590,000USD-30,614,000USD-20,749,000USD-13,141,000USD-35,225,000USD23,023,000USD98,470,000USD
    Ebitda-19,601,000USD-13,574,000USD-30,555,000USD-20,615,000USD-13,006,000USD-35,157,000USD23,057,000USD98,503,000USD
    Depreciation And Amortization17,000USD16,000USD59,000USD134,000USD135,000USD68,000USD34,000USD33,000USD
    Reconciled Depreciation17,000USD16,000USD59,000USD134,000USD135,000USD68,000USD34,000USD33,000USD
    Total Other Income Expense Net1,283,000USD6,152,000USD-11,416,000USD-1,433,000USD1,528,000USD-21,914,000USD35,884,000USD108,045,000USD
    Selling And Marketing Expenses—381,000USD———789,000USD142,000USD21,000USD
    Unclassified Operating Expenses——-9,968,000USD-10,604,000USD-5,900,000USD———
    Interest Expense——————964,000USD1,039,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20192019-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue59,000USD441,000USD6,750,351USD1,153,000USD——
    Cost Of Revenue344,000USD-366,000USD-566,523USD8,239,000USD23,508USD—
    Gross Profit59,000USD807,000USD7,316,874USD-7,086,000USD-23,508USD—
    Research Development50,084,000USD52,078,000USD11,764,133USD10,150,000USD6,587,000USD8,914,084USD
    Selling General Administrative22,430,000USD16,452,000USD10,123,000USD7,083,000USD4,423,000USD4,020,364USD
    Selling And Marketing Expenses470,000USD789,000USD1,484,044USD———
    Total Operating Expenses72,984,000USD69,319,000USD23,454,282USD17,233,000USD11,010,000USD12,934,448USD
    Operating Income-72,925,000USD-68,512,000USD-16,137,408USD-16,080,000USD-11,010,000USD-12,934,448USD
    Net Interest Income4,351,000USD3,317,000USD121,326USD———
    Income Before Tax-78,094,000USD-35,015,000USD-15,990,117USD-16,471,000USD-10,490,000USD-13,045,008USD
    Income Tax Expense165,000USD114,000USD280,316USD364,144USD-543,508USD110,560USD
    Tax Provision165,000USD114,000USD280,316USD———
    Net Income-78,259,000USD-35,129,000USD-16,072,547USD-16,471,000USD-10,490,000USD-13,045,008USD
    Net Income From Continuing Ops-78,259,000USD-35,129,000USD-16,270,753USD———
    Ebit-78,094,000USD-35,015,000USD-17,393,299USD-16,080,047USD-10,481,947USD-12,934,448USD
    Ebitda-77,750,000USD-34,846,000USD-13,509,732USD-16,053,191USD-10,458,439USD-12,914,416USD
    Depreciation And Amortization344,000USD169,000USD3,883,567USD26,856USD23,508USD20,032USD
    Reconciled Depreciation344,000USD169,000USD3,883,567USD———
    Total Other Income Expense Net-5,169,000USD33,497,000USD147,291USD-391,556USD519,844USD-110,560USD
    Interest Expense—3,317,000USD2,907,000USD464,181USD793,205USD10,555USD
    Interest Income——121,326USD———
    Discontinued Operations——198,206USD———
    Net Income Applicable To Common Shares——-16,072,547USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets490,783,000USD99,885,000USD116,458,000USD125,100,000USD126,583,000USD138,523,000USD150,732,000USD98,455,000USD
    Cash And Equivalents85,382,000USD———————
    Cash And Short Term Investments400,276,000USD81,993,000USD98,336,000USD111,617,000USD113,262,000USD125,046,000USD134,546,000USD81,858,000USD
    Short Term Investments314,894,000USD57,005,000USD82,478,000USD84,654,000USD70,972,000USD—0USD—
    Long Term Investments71,878,000USD———————
    Total Current Assets407,932,000USD88,825,000USD105,286,000USD113,846,000USD115,185,000USD126,941,000USD138,890,000USD86,148,000USD
    Other Current Assets7,607,000USD6,832,000USD6,950,000USD2,229,000USD1,923,000USD1,895,000USD3,733,000USD3,292,000USD
    Total Liabilities42,123,000USD———————
    Total Current Liabilities21,130,000USD11,599,000USD12,940,000USD7,972,000USD9,259,000USD5,615,000USD6,960,000USD60,674,000USD
    Other Non Current Liabilities0USD———————
    Total Stockholder Equity448,660,000USD68,320,000USD83,049,000USD91,547,000USD104,574,000USD122,615,000USD133,032,000USD21,076,000USD
    Total Equity Including Noncontrolling Interest448,660,000USD———————
    Goodwill10,502,000USD———————
    Accounts Payable3,347,000USD356,000USD137,000USD474,000USD2,366,000USD681,000USD283,000USD1,811,000USD
    Common Stock53,000USD25,000USD18,000USD18,000USD11,000USD11,000USD10,000USD10,000USD
    Retained Earnings-504,510,000USD-468,152,000USD-448,522,000USD-434,802,000USD-404,177,000USD-383,412,000USD-370,263,000USD-334,924,000USD
    Accumulated Other Comprehensive Income-583,000USD-6,000USD68,000USD41,000USD-34,000USD——-1,658,000USD
    Total Liab—31,565,000USD33,409,000USD33,553,000USD22,009,000USD15,908,000USD17,700,000USD77,379,000USD
    Other Current Liab—10,915,000USD12,411,000USD7,060,000USD6,411,000USD4,408,000USD6,109,000USD58,313,000USD
    Capital Stock—25,000USD18,000USD18,000USD11,000USD11,000USD10,000USD10,000USD
    Good Will—10,502,000USD10,502,000USD10,502,000USD10,502,000USD10,502,000USD10,502,000USD10,502,000USD
    Cash—24,988,000USD15,858,000USD26,963,000USD42,290,000USD125,046,000USD134,546,000USD81,858,000USD
    Net Debt—-22,660,000USD-13,431,000USD-26,408,000USD-41,611,000USD-124,245,000USD-133,978,000USD-81,308,000USD
    Short Term Debt—328,000USD392,000USD438,000USD482,000USD526,000USD568,000USD550,000USD
    Short Long Term Debt Total—2,328,000USD2,427,000USD555,000USD679,000USD801,000USD568,000USD550,000USD
    Property Plant Equipment Net—375,000USD460,000USD542,000USD686,000USD949,000USD1,209,000USD1,674,000USD
    Common Stock Shares Outstanding—20,106,925shares18,512,757shares14,000,451shares10,829,760shares10,514,901shares10,471,934shares10,784,037shares
    Non Current Assets Total—11,060,000USD11,172,000USD11,254,000USD11,398,000USD11,582,000USD11,842,000USD12,307,000USD
    Non Current Liabilities Total—19,966,000USD20,469,000USD25,581,000USD12,750,000USD10,293,000USD10,740,000USD16,705,000USD
    Non Current Liabilities Other—2,000,000USD2,035,000USD2,000,000USD2,000,000USD2,000,000USD2,350,000USD3,083,000USD
    Non Currrent Assets Other—183,000USD210,000USD210,000USD210,000USD131,000USD131,000USD131,000USD
    Net Working Capital—77,226,000USD92,346,000USD105,874,000USD105,926,000USD121,326,000USD131,930,000USD25,474,000USD
    Unclassified Non Current Liabilities—17,966,000USD18,434,000USD23,581,000USD10,750,000USD8,293,000USD8,390,000USD13,622,000USD
    Unclassified Equity—536,428,000USD531,467,000USD526,272,000USD508,763,000USD506,005,000USD503,275,000USD357,638,000USD
    Property Plant Equipment Gross——713,000USD———1,919,000USD—
    Net Receivables——————611,000USD998,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets116,458,000USD150,732,000USD20,993,000USD33,367,000USD80,214,000USD43,755,000USD36,108,970USD70,250,721USD
    Other Current Assets6,950,000USD3,733,000USD844,000USD1,305,000USD2,423,000USD2,698,000USD1,222,080USD10,145,342USD
    Total Liab33,409,000USD17,700,000USD13,689,000USD44,282,000USD57,132,000USD19,193,000USD15,113,405USD49,342,973USD
    Total Stockholder Equity83,049,000USD133,032,000USD7,304,000USD-10,915,000USD23,082,000USD24,562,000USD20,995,565USD20,907,748USD
    Other Current Liab12,411,000USD6,109,000USD3,635,000USD12,682,000USD16,034,000USD12,225,000USD9,375,449USD22,738,180USD
    Common Stock18,000USD10,000USD1,000USD9,000USD9,000USD75,000USD44,384USD40,804USD
    Capital Stock18,000USD10,000USD1,000USD9,000USD113,000USD76,260USD47,241USD43,661USD
    Retained Earnings-448,522,000USD-370,263,000USD-335,134,000USD-303,824,000USD-262,166,000USD-177,790,000USD-114,290,617USD-98,218,070USD
    Good Will10,502,000USD10,502,000USD10,502,000USD14,409,000USD14,409,000USD14,409,000USD14,409,088USD16,411,123USD
    Cash15,858,000USD134,546,000USD7,415,000USD13,172,000USD54,585,000USD18,919,000USD3,609,438USD10,646,301USD
    Cash And Short Term Investments98,336,000USD134,546,000USD7,415,000USD13,172,000USD54,585,000USD18,919,000USD11,238,385USD10,646,301USD
    Total Current Assets105,286,000USD138,890,000USD8,395,000USD16,416,000USD61,845,000USD26,005,000USD17,724,016USD21,931,893USD
    Total Current Liabilities12,940,000USD6,960,000USD4,618,000USD22,114,000USD19,888,000USD15,225,000USD12,160,459USD26,216,579USD
    Net Debt-13,431,000USD-133,978,000USD-6,878,000USD6,776,000USD-21,267,000USD-18,493,000USD-3,453,623USD4,731,581USD
    Short Term Debt392,000USD568,000USD537,000USD6,462,000USD485,000USD426,000USD155,815USD1,050,000USD
    Short Long Term Debt Total2,427,000USD568,000USD537,000USD19,948,000USD33,318,000USD426,000USD155,815USD15,377,882USD
    Short Term Investments82,478,000USD0USD———0USD7,628,947USD—
    Accounts Payable137,000USD283,000USD446,000USD2,882,000USD3,369,000USD2,574,000USD2,077,524USD1,446,141USD
    Property Plant Equipment Net460,000USD1,209,000USD1,965,000USD2,411,000USD2,695,000USD1,607,000USD1,447,663USD586,512USD
    Property Plant Equipment Gross713,000USD1,919,000USD2,507,000USD2,825,000USD2,981,000USD1,607,070USD1,447,663USD586,512USD
    Accumulated Other Comprehensive Income68,000USD————0USD0USD-132,163USD
    Common Stock Shares Outstanding13,404,830shares10,784,037shares277,727shares39,202shares36,191shares25,511shares19,849shares12,074shares
    Non Current Assets Total11,172,000USD11,842,000USD12,598,000USD16,951,000USD18,369,000USD17,750,000USD18,384,954USD48,318,828USD
    Non Current Liabilities Total20,469,000USD10,740,000USD9,071,000USD22,168,000USD37,244,000USD3,968,000USD2,952,946USD23,126,394USD
    Non Current Liabilities Other2,035,000USD2,350,000USD3,366,000USD3,711,000USD4,298,000USD3,878,395USD1,111,965USD8,729,274USD
    Non Currrent Assets Other210,000USD131,000USD131,000USD131,000USD1,227,000USD149,000USD101,945USD-91,236USD
    Net Working Capital92,346,000USD131,930,000USD3,777,000USD-5,698,000USD41,957,000USD10,780,408USD5,563,557USD-4,284,686USD
    Unclassified Non Current Liabilities18,434,000USD8,390,000USD5,705,000USD-2,000,000USD-4,298,000USD-2,931,185USD—-23,057,156USD
    Unclassified Equity531,467,000USD503,275,000USD342,436,000USD292,891,000USD285,126,000USD202,200,740USD135,194,557USD119,173,516USD
    Net Receivables—611,000USD136,000USD1,919,000USD4,799,000USD4,385,000USD5,242,217USD6,084,540USD
    Other Assets——1USD—1,227,000USD148,642USD101,945USD29,557,974USD
    Inventory——0USD20,000USD38,000USD3,000USD21,334USD1,110,780USD
    Other Liab———6,971,000USD4,411,000USD2,930,395USD1,840,981USD23,126,394USD
    Current Deferred Revenue———88,000USD16,025,000USD10,883,654USD-155,815USD2,032,258USD
    Short Long Term Debt———5,930,000USD———1,050,000USD
    Long Term Debt———13,486,000USD32,833,000USD——14,327,882USD
    Net Tangible Assets———-25,324,000USD8,635,000USD8,567,330USD4,160,219USD2,733,406USD
    Unclassified Current Liabilities———-5,930,000USD-16,025,000USD-10,883,654USD—-2,100,000USD
    Intangible Assets————38,000USD1,585,000USD2,426,258USD31,239,468USD
    Unclassified Non Current Assets————-1,227,000USD——-29,476,249USD
    Deferred Long Term Liab—————90,395USD——
    Unclassified Current Assets———————-6,055,070USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-19,630,000USD-13,720,000USD-30,625,000USD-20,765,000USD-13,149,000USD-35,339,000USD23,037,000USD98,463,000USD
    Depreciation17,000USD16,000USD59,000USD134,000USD135,000USD68,000USD34,000USD33,000USD
    Stock Based Compensation3,575,000USD4,508,000USD3,154,000USD2,718,000USD3,241,000USD2,904,000USD1,848,000USD471,000USD
    Other Non Cash Items-586,000USD-5,357,000USD12,183,000USD2,384,000USD-380,000USD17,821,000USD-34,925,000USD-113,931,000USD
    Change In Working Capital-1,079,000USD176,000USD-1,146,000USD3,614,000USD1,197,000USD-612,000USD-1,507,000USD-1,326,000USD
    Total Cash From Operating Activities-17,691,000USD-14,246,000USD-16,365,000USD-11,390,000USD-9,457,000USD-15,044,000USD-11,527,000USD-16,283,000USD
    Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
    Free Cash Flow-17,691,000USD-14,246,000USD-16,365,000USD-11,390,000USD-9,457,000USD-15,044,000USD-11,527,000USD-16,283,000USD
    Investments25,505,000USD2,401,000USD-13,261,000USD-70,860,000USD0USD0USD0USD0USD
    Total Cashflows From Investing Activities25,505,000USD2,401,000USD-13,261,000USD-70,860,000USD———356,000USD
    Total Cash From Financing Activities1,399,000USD687,000USD14,369,000USD-469,000USD0USD67,709,000USD0USD-472,000USD
    Change In Cash9,213,000USD-11,158,000USD-15,257,000USD-82,798,000USD-9,457,000USD52,666,000USD-11,527,000USD-16,755,000USD
    Begin Period Cash Flow16,105,000USD27,263,000USD42,520,000USD125,108,000USD134,696,000USD81,899,000USD93,557,000USD110,312,000USD
    End Period Cash Flow25,318,000USD16,105,000USD27,263,000USD42,310,000USD125,239,000USD134,565,000USD82,030,000USD93,557,000USD
    Other Cashflows From Investing Activities106,000USD197,000USD10,500,000USD146,000USD———356,000USD
    Other Cashflows From Financing Activities-779,000USD687,000USD-1,000USD-509,000USD—-117,359,000USD-12,272,000USD-472,000USD
    Unclassified Financing Cash Flow2,178,000USD————185,068,000USD12,272,000USD—
    Sale Purchase Of Stock—-17,000USD—40,000USD————
    Issuance Of Capital Stock—392,000USD14,370,000USD0USD0USD0USD0USD0USD
    Unclassified Investing Cash Flow——-10,500,000USD—————
    Net Borrowings————0USD0USD0USD—
    Change To Account Receivables—————387,000USD-965,000USD2,000USD
    Change To Inventory—————0USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-78,259,000USD-35,129,000USD-31,544,000USD-41,658,000USD-84,376,000USD-63,500,000USD-16,072,547USD-40,052,810USD
    Depreciation344,000USD169,000USD158,000USD166,000USD1,657,000USD1,843,000USD3,883,567USD4,554,963USD
    Stock Based Compensation13,621,000USD5,852,000USD3,477,000USD7,554,000USD8,172,000USD6,786,000USD2,532,257USD2,431,063USD
    Other Non Cash Items8,830,000USD-15,354,000USD6,455,000USD2,389,000USD794,000USD18,572,000USD-7,467,745USD21,222,325USD
    Change In Working Capital3,841,000USD-4,708,000USD-9,240,000USD4,770,000USD2,839,000USD-4,437,000USD-2,026,607USD8,733,102USD
    Total Cash From Operating Activities-51,458,000USD-49,056,000USD-30,680,000USD-26,751,000USD-70,892,000USD-40,539,000USD-19,134,332USD-3,128,102USD
    Capital Expenditures0USD0USD-158,000USD-95,000USD-113,000USD-63,000USD-262,013USD-564,415USD
    Free Cash Flow-51,458,000USD-49,056,000USD-30,838,000USD-26,846,000USD-71,005,000USD-40,602,000USD-19,396,345USD-3,692,517USD
    Investments-81,720,000USD356,000USD-133,000USD-95,000USD-113,000USD12,836,736USD12,836,736USD12,836,736USD
    Total Cashflows From Investing Activities-81,720,000USD356,000USD-133,000USD-95,000USD-113,000USD11,132,000USD-443,002USD865,461USD
    Total Cash From Financing Activities14,587,000USD175,849,000USD25,042,000USD-14,699,000USD106,762,000USD44,784,000USD12,559,496USD10,403,898USD
    Sale Purchase Of Stock23,000USD68,000USD67,000USD73,000USD366,000USD-93,869USD-33,959USD—
    Issuance Of Capital Stock14,762,000USD115,625,000USD46,252,000USD34,000USD71,929,000USD44,452,138USD12,684,562USD3,857,106USD
    Change In Cash-118,591,000USD127,149,000USD-5,771,000USD-41,545,000USD35,757,000USD15,377,000USD-7,017,838USD8,141,257USD
    Begin Period Cash Flow134,696,000USD7,547,000USD13,318,000USD54,863,000USD19,106,000USD3,729,000USD10,746,756USD2,605,499USD
    End Period Cash Flow16,105,000USD134,696,000USD7,547,000USD13,318,000USD54,863,000USD19,106,000USD3,728,918USD10,746,756USD
    Other Cashflows From Investing Activities690,000USD356,000USD25,000USD——-1,641,819,000,000USD3,958,412USD-1,000USD
    Other Cashflows From Financing Activities-510,000USD60,224,000USD67,000USD14,806,000USD1,933,000USD332,000USD1,245,957USD6,546,792USD
    Unclassified Financing Cash Flow15,074,000USD115,557,000USD46,152,000USD—104,463,000USD11,645,869USD12,684,562USD—
    Change To Account Receivables—-475,000USD1,783,000USD1,060,000USD1,117,000USD-2,785,000USD1,658,333USD-222,530USD
    Change To Inventory—0USD20,000USD18,000USD-35,000USD18,000USD532,947USD-311,199USD
    Net Borrowings—0USD-21,244,000USD-14,806,000USD32,900,000USD32,900,000USD-256,140USD-256,140USD
    Change To Liabilities———0USD796,000USD98,520USD1,019,358USD82,451USD
    Dividends Paid———-14,806,000USD-32,900,000USD—-1,080,924USD—
    Cash And Cash Equivalents Changes—————15,377,094USD——
    Unclassified Investing Cash Flow—————1,641,817,358,264USD-16,976,137USD-11,405,860USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2024Yearly · 2024-12-31ProductLicense0USD0001628280-25-013986
    FY 2024Yearly · 2024-12-31ProductOther41,000USD0001628280-25-013986
    FY 2024Yearly · 2024-12-31ProductProduct400,000USD0001628280-25-013986
    FY 2023Yearly · 2023-12-31ProductLicense516,000USD0001628280-25-013986
    FY 2023Yearly · 2023-12-31ProductOther8,000USD0001628280-25-013986
    FY 2023Yearly · 2023-12-31ProductProduct1,400,000USD0001628280-25-013986
    Q3 2023Quarterly · 2023-09-30ProductLicense0USD0001628280-23-038036
    Q3 2023Quarterly · 2023-09-30ProductOther36,000USD0001628280-23-038036
    Q3 2023Quarterly · 2023-09-30ProductProduct200,000USD0001628280-23-038036
    Q3 2022Quarterly · 2022-09-30ProductLicense14,517,000USD0001628280-23-038036
    Q3 2022Quarterly · 2022-09-30ProductOther32,000USD0001628280-23-038036
    Q3 2022Quarterly · 2022-09-30ProductProduct400,000USD0001628280-23-038036
    Q2 2022Quarterly · 2022-06-30ProductLicense0USD0001628280-22-020866
    Q2 2022Quarterly · 2022-06-30ProductOther33,000USD0001628280-22-020866
    Q2 2022Quarterly · 2022-06-30ProductProduct1,000,000USD0001628280-22-020866
    FY 2021Yearly · 2021-12-31ProductLicense625,000USD0001628280-23-009630
    FY 2021Yearly · 2021-12-31ProductProduct4,800,000USD0001628280-23-009630
    Q2 2021Quarterly · 2021-06-30ProductLicense625,000USD0001628280-22-020866
    Q2 2021Quarterly · 2021-06-30ProductOther30,000USD0001628280-22-020866
    Q2 2021Quarterly · 2021-06-30ProductProduct2,700,000USD0001628280-22-020866
    FY 2020Yearly · 2020-12-31ProductLicense0USD0001628280-22-004671
    FY 2020Yearly · 2020-12-31ProductProduct6,700,000USD0001628280-22-004671
    Q3 2020Quarterly · 2020-09-30ProductLicense0USD0001628280-21-022546
    Q3 2020Quarterly · 2020-09-30ProductOther11,000USD0001628280-21-022546
    Q3 2020Quarterly · 2020-09-30ProductProduct1,100,000USD0001628280-21-022546
    Q2 2020Quarterly · 2020-06-30ProductLicense0USD0001628280-21-015170
    Q2 2020Quarterly · 2020-06-30ProductOther38,000USD0001628280-21-015170
    Q2 2020Quarterly · 2020-06-30ProductProduct1,300,000USD0001628280-21-015170
    FY 2019Yearly · 2019-12-31ProductLicense100,000USD0001628280-21-004162
    FY 2019Yearly · 2019-12-31ProductProduct6,700,000USD0001628280-21-004162
    Q3 2019Quarterly · 2019-09-30ProductLicense100,000USD0001628280-20-016113
    Q3 2019Quarterly · 2019-09-30ProductProduct2,100,000USD0001628280-20-016113
    Q2 2019Quarterly · 2019-06-30ProductSales Force Revenue0USD0001628280-19-010465
    Q2 2019Quarterly · 2019-06-30ProductSales Revenue Product — Prescribed Dietary Supplements1,800,000USD0001628280-19-010465
    Q2 2019Quarterly · 2019-06-30ProductSales Revenue Product — Prescription Drugs2,649,000USD0001628280-19-010465
    FY 2017Yearly · 2017-12-31ProductGrant Revenue624,569USD0001628280-19-003078
    FY 2017Yearly · 2017-12-31ProductLicense25,000,000USD0001628280-19-003078
    FY 2017Yearly · 2017-12-31ProductSales Force Revenue278,165USD0001628280-19-003078
    FY 2017Yearly · 2017-12-31ProductSales Revenue Product — Prescribed Dietary Supplements1,092,271USD0001628280-19-003078
    FY 2017Yearly · 2017-12-31ProductSales Revenue Product — Prescription Drugs818,132USD0001628280-19-003078

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.